Skip to main content
. 2018 Nov 1;8(11):2296–2310.

Table 1.

Relationship between lncRNA ANRIL expression and their clinicopathologic parameters in 49 of HNSCC patients

Clinicopathologic parameters Number of cases Median expression of lncRNA ANRIL

Mean ± s.d. P-value
Gender
    Male 28 1.6992±0.3211 0.7
    Female 21 1.4165±0.3091
Ages, years
    ≤ 59 24 1.6667±0.3402 0.336
    > 59 25 1.4753±0.2951
T stage, TNM
    T1+T2 37 1.3665±0.2247 0.005
    T3+T4 12 1.7262±0.4983
Clinical stage
    I-II 18 1.2038±0.2692 0.058
    III-IV 31 1.7124±0.3181
Lymph node metastasis
    Absent 26 1.1078±0.2173 0.001
    Present 23 1.6925±0.3529
Alcohol drinking
    Absent 27 1.4706±0.2830 0.427
    Present 22 1.7131±0.3652
Smoking
    Absent 30 1.6199±0.2958 0.335
    Present 19 1.4911±0.3421
Location
    Lips 12 1.8201±0.5256
    Cheek 5 1.0918±0.4883 0.304
    Buccal mucosa 13 1.2690±0.3520
    Tongue 19 1.6466±0.3778

Abbreviations: HNSCC, head and neck squamous cell carcinoma; TNM, tumor node metastasis. P-value represents the probability from a Student’s t-test for lncRNA ANRIL expression between variable subgroups.